Athira Pharma Statistics
Total Valuation
Athira Pharma has a market cap or net worth of $11.32 million. The enterprise value is -$38.15 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, after market close.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Athira Pharma has 39.04 million shares outstanding. The number of shares has increased by 1.21% in one year.
Current Share Class | 39.04M |
Shares Outstanding | 39.04M |
Shares Change (YoY) | +1.21% |
Shares Change (QoQ) | +0.48% |
Owned by Insiders (%) | 8.46% |
Owned by Institutions (%) | 21.43% |
Float | 27.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.27 |
P/TBV Ratio | 0.27 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.03.
Current Ratio | 4.18 |
Quick Ratio | 3.90 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -110.77% and return on invested capital (ROIC) is -68.02%.
Return on Equity (ROE) | -110.77% |
Return on Assets (ROA) | -55.23% |
Return on Invested Capital (ROIC) | -68.02% |
Return on Capital Employed (ROCE) | -212.02% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.73M |
Employee Count | 26 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.09% in the last 52 weeks. The beta is 3.01, so Athira Pharma's price volatility has been higher than the market average.
Beta (5Y) | 3.01 |
52-Week Price Change | -88.09% |
50-Day Moving Average | 0.42 |
200-Day Moving Average | 1.22 |
Relative Strength Index (RSI) | 33.26 |
Average Volume (20 Days) | 212,407 |
Short Selling Information
The latest short interest is 1.04 million, so 2.67% of the outstanding shares have been sold short.
Short Interest | 1.04M |
Short Previous Month | 886,263 |
Short % of Shares Out | 2.67% |
Short % of Float | 3.78% |
Short Ratio (days to cover) | 4.26 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -96.78M |
Pretax Income | -113.45M |
Net Income | -96.94M |
EBITDA | -95.81M |
EBIT | -96.78M |
Earnings Per Share (EPS) | -$2.52 |
Full Income Statement Balance Sheet
The company has $51.28 million in cash and $1.22 million in debt, giving a net cash position of $50.06 million or $1.28 per share.
Cash & Cash Equivalents | 51.28M |
Total Debt | 1.22M |
Net Cash | 50.06M |
Net Cash Per Share | $1.28 |
Equity (Book Value) | 44.84M |
Book Value Per Share | 1.15 |
Working Capital | 41.71M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$97.17 million and capital expenditures -$33,000, giving a free cash flow of -$97.20 million.
Operating Cash Flow | -97.17M |
Capital Expenditures | -33,000 |
Free Cash Flow | -97.20M |
FCF Per Share | -$2.49 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Athira Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.21% |
Shareholder Yield | n/a |
Earnings Yield | -814.08% |
FCF Yield | -816.29% |
Analyst Forecast
The average price target for Athira Pharma is $11.25, which is 3,779.31% higher than the current price. The consensus rating is "Buy".
Price Target | $11.25 |
Price Target Difference | 3,779.31% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |